18 May 2017 | Pleiotropic Effects of Trait-Associated Genetic Variation on DNA Methylation: Utility for Refining GWAS Loci
| Hannon, E; Weedon, M; Bray, N; et al. |
2 March 2022 | PLIN1 haploinsufficiency causes a favorable metabolic profile
| Patel, KA; Burman, S; Laver, TW; et al. |
17 July 2018 | PLIN1 haploinsufficiency is not associated with lipodystrophy
| Laver, TW; Patel, KA; Colclough, K; et al. |
3 April 2017 | Polycystic kidney disease with hyperinsulinemic hypoglycemia caused by a promoter mutation in phosphomannomutase 2.
| Cabezas, OR; Flanagan, SE; Stanescu, H; et al. |
21 July 2017 | Population-based assessment of a biomarker-based screening pathway to aid diagnosis of monogenic diabetes in young-onset patients
| Shields, B; Shepherd, M; Hudson, M; et al. |
23 May 2013 | Population-based estimates of the prevalence of FMR1 expansion mutations in women with early menopause and primary ovarian insufficiency.
| Murray, A; Schoemaker, MJ; Bennett, CE; et al. |
18 September 2020 | Potentially inappropriate prescribing in dementia, multi-morbidity and incidence of adverse health outcomes
| Delgado, J; Jones, L; Bradley, MC; et al. |
28 April 2016 | Practical Classification Guidelines for Diabetes in patients treated with insulin: a cross-sectional study of the accuracy of diabetes diagnosis
| Hope, SV; Wienand-Barnett, S; Shepherd, M; et al. |
28 April 2016 | Practical Classification Guidelines for Diabetes in patients treated with insulin: a cross-sectional study of the accuracy of diabetes diagnosis
| Hope, Suzy; Wienand-Barnett, Sophie; Shepherd, Maggie H.; et al. |
25 June 2015 | Practical considerations in improving research through public involvement
| Jenner, MK; Gilchrist, M; Baker, GC |
17 March 2017 | Precision diabetes: learning from monogenic diabetes
| Hattersley, AT; Patel, KA |
31 January 2018 | Precision medicine in Type 2 diabetes: Clinical markers of insulin resistance are associated with altered short and long-term glycemic response to DPP4-inhibitor therapy
| Dennis, J; Shields, B; Hill, A; et al. |
30 September 2019 | Precision medicine in type 2 diabetes: harnessing individual-level trial data alongside routine care records to identify predictors of response to SGLT2 inhibitors and DPP4 inhibitors
| Dennis, JM; Henley, W; Jones, A; et al. |
25 August 2020 | Precision medicine in type 2 diabetes: Using individualised prediction models to optimise selection of treatment
| Dennis, JM |
2 April 2020 | Predicting incident delirium diagnoses using data from primary-care electronic health records
| Bowman, K; Jones, L; Masoli, J; et al. |
8 November 2021 | Predicting novel candidate human obesity genes and their site of action by systematic functional screening in Drosophila.
| Agrawal, N; Lawler, K; Davidson, CM; et al. |
21 July 2020 | Predicting post one-year durability of glucose-lowering monotherapies in patients with newly-diagnosed type 2 diabetes mellitus – A MASTERMIND precision medicine approach (UKPDS 87)
| Agbaje, OF; Coleman, RL; Hattersley, AT; et al. |
27 February 2019 | Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study
| Kennedy, NA; Heap, GA; Green, HD; et al. |
20 July 2020 | Preexisting comorbidities predicting Covid-19 and mortality in the UK biobank community cohort
| Atkins, J; Masoli, J; Correa-Delgado, J; et al. |
1 September 2016 | Prematurity should not prevent genetic testing for neonatal diabetes
| Besser, RE; Flanagan, SE; Mackay, DG; et al. |